Fig. 2

Impact of PCSK9 on cardiovascular risk via EV release. PCSK9 expression induces a pro-inflammatory state through the activation of platelets, macrophages, and endothelial cells mediated by the release of EVs. PCSK9 proprotein convertase subtilisin/kexin type 9, IL interleukin. Created with Biorender.com